Cathy Heitman
-
Posted On Herpes Research
ISSTDR Conference Review
HSV-2 prevalence, stigma among topics covered at major STD research meeting Studies that focused on the clinical and emotional aspects of herpes were among those…
-
Posted On Herpes Research
Promise for a New HSV Treatment Option?
A study finds a new class of anti-viral drug significantly reduces both genital shedding and lesions related to HSV-2. The only class of drugs currently…
-
Posted On Herpes Research
Stress and Depression Linked with Herpes Outbreaks
Stress, worry, and bouts of feeling blue are all but unavoidable in the modern world. For those with genital herpes, daily pressures might increase the…
-
Posted On Herpes Research
Study: HSV/HIV Co-infection is Common
Results from a large study spanning 15 years confirm that HSV infections are common among HIV patients. Researchers from the University of Washington and the…
-
Posted On Vaccine News
NIAID Awards Grant for HSV Vaccine Research
The National Institute of Allergy and Infectious Diseases (NIAID) recently awarded a 2-year, $600,000 Phase I Small Business Innovation and Research (SBIR) grant to GenVec,…
-
Posted On Vaccine News
Measuring the Impact of an HSV Vaccine
What kind of impact would a herpes vaccine have on the general population? A recently completed study uses mathematical modeling to gauge the population level…
-
Posted On Vaccine News
Herpes Vaccine Not Effective in Women
Results from a Phase III clinical trial found an experimental vaccine that showed early promise is not effective in preventing genital herpes disease in women.…
-
Posted On Vaccine News
What’s New in Herpes Vaccine Research
HerpV (formerly AG-707)Agenus, Inc, formerly named Antigenics, Inc, reported on developments of their experimental herpes vaccine, AG-707, now renamed HerpV. HerpV is intended as a…
-
Posted On Vaccine News
Vical Vaccine
The manufacturer of an experimental vaccine for HSV-2 that showed therapeutic efficacy in animal research has announced plans to begin human safety studies in 2012. Vical…
-
Posted On Vaccine News
Disappointing HSV Vaccine Results
An experimental HSV vaccine was not effective in preventing genital HSV-2 infections or disease in women, according to data published in the New England Journal of…
Liyana Parker
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.